Summary & Overview
CPT 51596: Radical Cystectomy With Urinary Diversion
CPT code 51596 represents a radical cystectomy with urinary diversion — the complete removal of the bladder and adjacent organs with rerouting of urine. This procedure is a definitive surgical treatment for bladder cancer that is multifocal, recurrent, or not amenable to bladder-sparing approaches. It is a high-cost, high-acuity inpatient surgical service with important implications for surgical oncology, postoperative care, and long-term urinary reconstruction management.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, expected site-of-service and service type, and the common payer landscape. The publication highlights benchmarks related to utilization and reimbursement patterns, recent policy or coverage updates affecting radical cystectomy and urinary diversion, and coding considerations specific to this CPT code. Where input data is unavailable, the report notes that information is not provided. The content is intended for national audiences including health plan administrators, hospital billing teams, and clinical leaders seeking an authoritative summary of CPT code 51596.
Billing Code Overview
CPT code 51596 describes a surgical procedure in which the provider completely removes the urinary bladder and adjoining organs, most commonly performed for multifocal or recurrent bladder cancer. The procedure includes diversion of urine from the body using a variety of reconstruction or urinary rerouting techniques.
Service type: Major surgical oncology procedure with urinary diversion
Typical site of service: Inpatient hospital surgical setting, often performed in an operating room with postoperative inpatient recovery.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with multifocal high-grade urothelial carcinoma of the bladder presents after hematuria and failure of intravesical therapy. Imaging and transurethral biopsy confirm recurrent, muscle-invasive disease with tumors in multiple bladder regions. The multidisciplinary team schedules a radical cystectomy with urinary diversion. Preoperative workflow includes staging CT chest/abdomen/pelvis, cardiopulmonary evaluation, anesthesia assessment, consent for removal of the bladder and possible adjacent organs (prostate in men; uterus, ovaries in women), planning for diversion (ileal conduit, continent cutaneous diversion, or orthotopic neobladder), blood type and crossmatch, bowel preparation if required, and perioperative antibiotic and thromboembolism prophylaxis. Intraoperative steps include midline laparotomy or minimally invasive approach, complete cystectomy, pelvic lymphadenectomy, any necessary resection of adjacent organs, and construction of the chosen urinary diversion. Postoperative workflow includes ICU or step-down monitoring as needed, pain control, early ambulation, stoma care education (if ileal conduit), monitoring for complications (bleeding, infection, urine leak, ileus), pathology review, and oncology follow-up for adjuvant therapy planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard service | Used when no additional modifier applies and service is billed as primary procedure |